{"data":{"sci_version": "1.2", "schema": "https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json", "id": "pmid:33801812", "kind": "science-record", "revision": 8, "content_hash": "sha256:97a3e9302bce535b442df1483e8885c5d614e2c814bf1c3f8a361f03ba07ce9b", "created_at": "2026-11-01T15:41:31Z", "updated_at": "2026-11-01T22:46:26Z", "generator": {"name": "corpus-assay-engine", "run_id": "reading-sci-2026-11-01"}, "paper": {"state": "complete", "title": "Molecular Signature of Small Cell Lung Cancer after Treatment Failure: The MCM Complex as Therapeutic Target.", "doi": "10.3390/cancers13061187", "pmid": "33801812", "authors": ["Shunsuke Misono", "Keiko Mizuno", "Takayuki Suetsugu", "Kengo Tanigawa", "Nijiro Nohata", "Akifumi Uchida", "Hiroki Sanada", "Reona Okada", "Shogo Moriya", "Hiromasa Inoue", "Naohiko Seki"], "journal": "Cancers", "year": 2021, "abstract": "Small cell lung cancer (SCLC) is a highly aggressive cancer, and patients who become refractory to first-line treatment have a poor prognosis. The development of effective treatment regimens is urgently needed. In this study, we identified a gene expression signature of SCLC after treatment failure using SCLC clinical specimens (GEO accession number: GSE162102). A total of 1,136 genes were significantly upregulated in SCLC tissues. These upregulated genes were subjected to KEGG pathway analysis, and \"cell cycle\", \"Fanconi anemia\", \"alcoholism\", \"systemic lupus erythematosus\", \"oocyte meiosis\", \"homologous recombination\", \"DNA replication\", and \"p53 signaling\" were identified as the enriched pathways among the genes. We focused on the cell cycle pathway and investigated the clinical significance of four genes associated with this pathway: minichromosome maintenance (MCM) 2, MCM4, MCM6, and MCM7. The overexpression of these MCM genes was confirmed in SCLC clinical specimens. Knockdown assays using siRNAs targeting each of these four MCM genes showed significant attenuation of cancer cell proliferation. Moreover, siRNA-mediated knockdown of each MCM gene enhanced the cisplatin sensitivity of SCLC cells. Our SCLC molecular signature based on SCLC clinical specimens after treatment failure will provide useful information to identify novel molecular targets for this disease.", "claims": [{"id": "claim-method", "statement": "One-way analysis of variance (ANOVA) and Tukey’s post-hoc test were used for multiple group comparisons.", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:33801812", "locator": "sections[9] \"2.7. Statistical Analyses\" paragraph 2", "quote": "One-way analysis of variance (ANOVA) and Tukey’s post-hoc test were used for multiple group comparisons."}], "state": "complete"}, {"id": "claim-data-access", "statement": "Data is contained within the article or supplementary material.", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:33801812", "locator": "sections[23] \"Data Availability Statement\" paragraph 2", "quote": "Data is contained within the article or supplementary material."}], "state": "complete"}], "gaps": []}, "experiment": {"state": "complete", "objective": null, "steps": [{"id": "read_published_estimate", "order": 1, "name": "Read the published estimate from the source", "kind": "other", "state": "complete", "blocked_on": null, "description": "The claim, method and evidence span published with the source article.", "duration_hours": null, "parameters": {}, "inputs": ["source:pmid:33801812"], "outputs": ["the published estimate and its evidence"], "instruments": [], "reagents": []}, {"id": "obtain_source_data", "order": 2, "name": "Obtain the source data from the named repository", "kind": "data-preparation", "state": "complete", "blocked_on": null, "description": "The GEO series accession resolves and its sample accessions are listed. This lane did not download the dataset or read its licence.", "duration_hours": null, "parameters": {}, "inputs": ["data:geo:GSE162102"], "outputs": ["the source data with its repository provenance"], "instruments": [], "reagents": []}, {"id": "run_analysis", "order": 3, "name": "Run the published analysis", "kind": "analysis", "state": "complete", "blocked_on": null, "description": "Apply the paper's statistical method to the resolved series and compare the result with the published target.", "duration_hours": null, "parameters": {}, "inputs": ["data:geo:GSE162102"], "outputs": ["the replicated result and its comparison"], "instruments": [], "reagents": []}], "materials": [], "instruments": [], "reagents": [], "conditions": {}, "gaps": []}, "data": {"state": "partial", "assets": [{"id": "source:pmid:33801812", "role": "manuscript", "format": "xml", "media_type": "application/xml", "uri": "https://doi.org/10.3390/cancers13061187", "sha256": "sha256:c3d25e83675215f029a5ccd47d0ab6739bc23bae62250469c460f706ef576b16", "bytes": 41086, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "10.3390/cancers13061187", "version": null, "note": "Full article fetched from PMC; the checksum covers the rendered section body, not the original XML bytes.", "structure": {"pmcid": "PMC7998124", "source": "europe_pmc_fulltext", "coverage": "whole_body", "text_hash_scope": "rendered_section_body"}}, {"id": "data:geo:GSE162102", "role": "raw", "format": "geo-series", "media_type": "application/vnd.ncbi.geo-series+json", "uri": "https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE162102", "sha256": null, "bytes": null, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "GSE162102", "version": null, "note": "Data is contained within the article or supplementary material.", "structure": {"repository": "GEO", "access_route": "GEO accession URL", "access_statement_verbatim": "Data is contained within the article or supplementary material.", "access_statement_kind": "data_availability_statement", "sample_accessions": ["GSM4933187", "GSM4933188", "GSM4933189", "GSM4933190", "GSM4933191", "GSM4933192", "GSM4933193", "GSM4933194", "GSM4933195", "GSM4933196", "GSM4933197", "GSM4933198"], "sample_count": 12, "group_sizes": null, "group_sizes_basis": null, "platform": "21185", "taxon": "Homo sapiens", "title": "Gene expression of autopsy samples from small cell lung cancer patients", "resolution_checked_at": "2026-11-01T15:39:54Z", "resolution_check": "identifier_resolution_only_no_download_no_licence_read", "downloaded": false, "licence_read": false}}, {"id": "asset:table:pmid:33801812:1", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:6a16bbdfce2c16d5d7c84e80fa0495711fca320cbcb888331f407a992cb15dab", "bytes": 615, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[11]/table-wrap[1]#cancers-13-01187-t001", "version": null, "note": "Clinical features of the SCLC patients.", "structure": {"pmcid": "PMC7998124", "section_index": 11, "section_title": "3.1. Clinical Course of SCLC Patients and Immunostaining of Autopsy Tissues", "row_count": 4, "column_count": 10}, "table": {"label": "Table 1", "caption": "Clinical features of the SCLC patients.", "rows": [["No.", "Sex", "Age", "BI", "T", "N", "M", "Stage", "Therapy", "Remarks"], ["1", "M", "67", "1440", "4", "2", "1b", "IV", "Platinum basedchemotherapy", "Microarray expression analysisIHC staining"], ["2", "M", "78", "1180", "2b", "2", "1b", "IV", "Platinum basedchemotherapy", "Microarray expression analysisIHC staining"], ["3", "M", "65", "990", "2a", "3", "1a", "IV", "Platinum basedchemotherapy", "Microarray expression analysisIHC staining"]], "row_count": 4, "column_count": 10, "numeric_cells": 18, "header_rows": 1, "locator": "section[11]/table-wrap[1]#cancers-13-01187-t001"}}, {"id": "asset:table:pmid:33801812:2", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:c168b8c00f29053d2a27cb68db5584de61bd789c4870bd9b7c490176cd02c260", "bytes": 918, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[11]/table-wrap[2]#cancers-13-01187-t002", "version": null, "note": "Site of sample collection for microarray expression analysis.", "structure": {"pmcid": "PMC7998124", "section_index": 11, "section_title": "3.1. Clinical Course of SCLC Patients and Immunostaining of Autopsy Tissues", "row_count": 16, "column_count": 3}, "table": {"label": "Table 2", "caption": "Site of sample collection for microarray expression analysis.", "rows": [["A. Cancer Tissues", "n = 8", ""], ["Sample Name", "Tissue", "Case No."], ["SCLC-Pri-1", "Primary lesion", "2"], ["SCLC-Pri-2", "Primary lesion", "3"], ["SCLC-Meta-1", "Lesser curvature lymph node metastasis", "1"], ["SCLC-Meta-2", "Mediastinal lymph node metastasis", "1"], ["SCLC-Meta-3", "Para-aortic lymph node metastasis", "1"], ["SCLC-Meta-4", "Right hilar lymph node metastasis", "2"], ["SCLC-Meta-5", "Liver metastasis", "1"], ["SCLC-Meta-6", "Right intrapulmonary metastasis", "3"], ["B. Normal lung tissues", "n = 4", ""], ["Sample name", "Tissue", "case no."], ["SCLC N-1", "Normal lung tissue", "1"], ["SCLC N-2", "Normal lung tissue", "1"], ["SCLC N-3", "Normal lung tissue", "2"], ["SCLC N-4", "Normal lung tissue", "3"]], "row_count": 16, "column_count": 3, "numeric_cells": 26, "header_rows": 2, "locator": "section[11]/table-wrap[2]#cancers-13-01187-t002"}}, {"id": "asset:table:pmid:33801812:3", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:2fc7ee31f72069d53d480c068c322d35e5f88a17d2978c8086fb2a1854207683", "bytes": 812, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[12]/table-wrap[1]#cancers-13-01187-t003", "version": null, "note": "Significantly enriched annotations of the upregulated genes identified by microarray expression analysis of SCLC clinical specimens.", "structure": {"pmcid": "PMC7998124", "section_index": 12, "section_title": "3.2. mRNA Expression Signature of SCLC after Treatment Failure", "row_count": 9, "column_count": 3}, "table": {"label": "Table 3", "caption": "Significantly enriched annotations of the upregulated genes identified by microarray expression analysis of SCLC clinical specimens.", "rows": [["No. of Genes", "p-Value", "Annotations"], ["28", "2.28 × 10−12", "(KEGG) 04110: Cell cycle"], ["15", "9.66 × 10−8", "(KEGG) 03460: Fanconi anemia pathway"], ["26", "6.19 × 10−7", "(KEGG) 05034: Alcoholism"], ["21", "2.12 × 10−6", "(KEGG) 05322: Systemic lupus erythematosus"], ["18", "7.67 × 10−5", "(KEGG) 04114: Oocyte meiosis"], ["10", "8.54 × 10−5", "(KEGG) 03440: Homologous recombination"], ["9", "1.92 × 10−4", "(KEGG) 03030: DNA replication"], ["10", "1.21 × 10−2", "(KEGG) 04115: p53 signaling pathway"]], "row_count": 9, "column_count": 3, "numeric_cells": 24, "header_rows": 1, "locator": "section[12]/table-wrap[1]#cancers-13-01187-t003"}}, {"id": "asset:table:pmid:33801812:4", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:a38bbcfd82365419f3069de61c2c1b7aea858836495f48f502beff23e1bd25e1", "bytes": 2911, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[13]/table-wrap[1]#cancers-13-01187-t004", "version": null, "note": "Upregulated genes associated with the cell cycle pathway.", "structure": {"pmcid": "PMC7998124", "section_index": 13, "section_title": "3.3. Expression of MCM2, MCM4, MCM6, MCM7 in SCLC Tissues", "row_count": 30, "column_count": 8}, "table": {"label": "Table 4", "caption": "Upregulated genes associated with the cell cycle pathway.", "rows": [["", "", "", "", "Normalized Read Count (Log2)"], ["EntrezGeneID", "GeneSymbol", "Gene Name", "Location", "Log2FoldChange", "NormalLungTissues", "SCLCTissues", "p-Value"], ["7272", "TTK", "TTK protein kinase", "6q14.1", "3.67", "−0.37", "3.30", "0.0034"], ["9134", "CCNE2", "cyclin E2", "8q22.1", "3.57", "0.05", "3.62", "0.0002"], ["4173", "MCM4", "minichromosome maintenance complex component 4", "8q11.21", "3.33", "0.20", "3.54", "0.0004"], ["699", "BUB1", "budding uninhibited by benzimidazoles 1 homolog", "2q13", "3.18", "−0.25", "2.92", "0.0040"], ["701", "BUB1B", "budding uninhibited by benzimidazoles 1 homolog beta", "15q15.1", "3.08", "−0.03", "3.05", "0.0018"], ["9133", "CCNB2", "cyclin B2", "15q22.2", "3.05", "0.05", "3.10", "0.0055"], ["1029", "CDKN2A", "cyclin-dependent kinase inhibitor 2A", "9p21.3", "3.01", "0.24", "3.25", "0.0047"], ["4171", "MCM2", "minichromosome maintenance complex component 2", "3q21.3", "2.96", "0.01", "2.97", "0.0008"], ["995", "CDC25C", "cell division cycle 25 homolog C", "5q31.2", "2.87", "−0.01", "2.87", "0.0045"], ["891", "CCNB1", "cyclin B1", "5q13.2", "2.82", "−0.06", "2.76", "0.0008"], ["1869", "E2F1", "E2F transcription factor 1", "20q11.22", "2.82", "−0.30", "2.52", "0.0100"], ["9700", "ESPL1", "extra spindle pole bodies homolog 1", "12q13.13", "2.70", "0.10", "2.80", "0.0007"], ["8318", "CDC45", "cell division cycle 45 homolog", "22q11.21", "2.64", "−0.29", "2.34", "0.0027"], ["8317", "CDC7", "cell division cycle 7 homolog", "1p22.2", "2.62", "0.01", "2.63", "0.0006"], ["4085", "MAD2L1", "MAD2 mitotic arrest deficient-like 1", "4q27", "2.61", "−0.19", "2.42", "0.0013"], ["898", "CCNE1", "cyclin E1", "19q12", "2.61", "0.06", "2.67", "0.0041"], ["1111", "CHEK1", "CHK1 checkpoint homolog", "11q24.2", "2.57", "0.00", "2.57", "0.0088"], ["993", "CDC25A", "cell division cycle 25 homolog A", "3p21.31", "2.50", "−0.15", "2.34", "0.0044"], ["9232", "PTTG1", "pituitary tumor-transforming 1", "5q33.3", "2.40", "0.07", "2.47", "0.0030"], ["983", "CDK1", "cyclin-dependent kinase 1", "10q21.2", "2.40", "0.05", "2.45", "0.0058"], ["10926", "DBF4", "DBF4 homolog", "7q21.12", "2.22", "0.06", "2.28", "0.0002"], ["4176", "MCM7", "minichromosome maintenance complex component 7", "7q22.1", "2.20", "0.13", "2.33", "0.0002"], ["890", "CCNA2", "cyclin A2", "4q27", "2.17", "0.03", "2.20", "0.0141"], ["4175", "MCM6", "minichromosome maintenance complex component 6", "2q21.3", "2.05", "−0.11", "1.94", "0.0002"], ["6502", "SKP2", "S-phase kinase-associated protein 2 (p45)", "5p13.2", "2.04", "0.23", "2.27", "0.0117"], ["5111", "PCNA", "proliferating cell nuclear antigen", "20p13", "2.04", "0.01", "2.05", "0.0017"], ["5591", "PRKDC", "protein kinase, DNA-activated, catalytic polypeptide", "8q11.21", "2.01", "−0.03", "1.98", "0.0071"], ["10744", "PTTG2", "pituitary tumor-transforming 2", "4p14", "2.00", "−0.01", "1.99", "0.0084"]], "row_count": 30, "column_count": 8, "numeric_cells": 189, "header_rows": 2, "locator": "section[13]/table-wrap[1]#cancers-13-01187-t004"}}], "gaps": ["asset:data:geo:GSE162102 not downloaded", "asset:data:geo:GSE162102 licence not read"]}, "analysis": {"state": "complete", "methods": [{"id": "method-1", "family": "group_comparison", "specific": "anova", "label": "Group comparison", "dsl_operations": ["group_summary", "welch_t", "bootstrap_mean_difference", "group_comparison_anova"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["two_or_more_groups_continuous"], "evidence": {"score": 1.0, "band": "verbatim", "quote": "One-way analysis of variance (ANOVA) and Tukey’s post-hoc test were used for multiple group comparisons."}}], "targets": [], "gaps": []}, "capability": {"state": "complete", "requirements": [{"capability_id": "capability:computational_analysis", "label": "Computational analysis platform", "assay_families": ["meta_analysis", "machine_learning", "survival_analysis", "statistical_regression", "pca", "molecular_docking", "network_analysis", "differential_expression", "gwas"], "availability_state": "owned", "tier_unlocked": "R1", "candidate": "Automated Assays Laravel application and simulated adapters"}], "gaps": []}, "readiness": {"state": "complete", "tier": "R1", "blocking_axis": "none", "blocked_on": "nothing:replicable_now", "axes": {"method": {"tier": "R1", "expressible": true, "required_operations": ["group_summary", "welch_t", "bootstrap_mean_difference", "group_comparison_anova"], "missing_operations": [], "basis": "The paper names the method it used and the corpus's method extractor maps it onto the DSL catalogue: anova."}, "capability": {"tier": "R1", "capability_id": "capability:computational_analysis", "availability_state": "owned", "basis": "The computational analysis is owned. The physical bench the paper used is not, so a physical validation cannot be run here."}, "data": {"tier": "R1", "reachable": true, "accessions": ["GSE162102"], "resolved_accessions": ["GSE162102"], "statements": ["Data is contained within the article or supplementary material."], "basis": "The paper names GSE162102 in Gene Expression Omnibus (GEO) and the accession resolves in the repository. No dataset was downloaded and no licence was read."}}, "can_run": {"dsl_operations": ["group_summary", "welch_t", "bootstrap_mean_difference", "group_comparison_anova"], "assets": ["source:pmid:33801812", "data:geo:GSE162102", "asset:table:pmid:33801812:1", "asset:table:pmid:33801812:2", "asset:table:pmid:33801812:3", "asset:table:pmid:33801812:4"], "steps": ["run_analysis"]}, "must_build": {"dsl_operations": [], "converters": [], "readers": [], "capabilities": [], "data_gaps": ["data:geo:GSE162102"]}, "gaps": []}, "review": {"state": "partial", "machine_critique": {"kind": "extraction_review", "reader": {"model": "MiniMax-M3.1-Flash", "provider": "minimax", "provider_family": "minimax", "read_at": "2026-10-31T18:28:45Z", "independence": "single_reader"}, "evidence_check": {"method": "verbatim", "availability": "verbatim"}, "calls": 3, "usage": {"prompt_tokens": 35549, "completion_tokens": 974, "cached_tokens": 256}}, "human_critique": null, "stages": [{"id": "extraction", "state": "complete", "reader": "MiniMax-M3.1-Flash", "provider": "minimax"}], "gaps": ["review.independent_reader", "review.machine_critique", "review.human_critique"]}, "execution": {"state": "absent", "status": "not_run", "mode": null, "runs": [], "gaps": ["execution.not_run"]}, "provenance": {"entities": [{"id": "pmid:33801812", "type": "paper", "label": "pmid:33801812"}, {"id": "source:pmid:33801812", "type": "manuscript", "label": "PMID 33801812 full text"}, {"id": "data:geo:GSE162102", "type": "dataset", "label": "GEO GSE162102"}], "activities": [{"id": "activity-reading-sci-2026-11-01", "type": "classification", "used": [{"id": "pmid:33801812", "type": "paper", "label": "pmid:33801812"}, {"id": "source:pmid:33801812", "type": "manuscript", "label": "PMID 33801812 full text"}, {"id": "data:geo:GSE162102", "type": "dataset", "label": "GEO GSE162102"}], "agent": "agent:corpus-assay-engine"}, {"id": "activity-read-33801812", "type": "extraction", "used": ["source:pmid:33801812"], "agent": "agent:minimax-reader"}, {"id": "activity-resolve-GSE162102", "type": "accession_resolution", "used": ["data:geo:GSE162102"], "agent": "agent:corpus-assay-engine"}], "agents": [{"id": "agent:corpus-assay-engine", "type": "software", "label": "Corpus assay engine"}, {"id": "agent:minimax-reader", "type": "software", "label": "MiniMax literature reader"}], "source_run_id": "reading-sci-2026-11-01", "dsl_catalogue_fingerprint": "343fb30756ba6ec3", "capability_table_fingerprint": "2cb3e42f047d2ecf", "snapshot_id": "ba34b49490d9bfaf"}, "lineage": {"parent_id": "pmid:33801812", "parent_hash": "sha256:5ed5c195df85f0bfe4980b1dfbdf2741914b80b15ffac7763df921694cc14c49", "fork_of": null, "generation": 7}, "gaps": ["asset:data:geo:GSE162102 licence not read", "asset:data:geo:GSE162102 not downloaded", "execution.not_run", "review.human_critique", "review.independent_reader", "review.machine_critique"], "assays": [{"role": "data_generation", "definition_id": "transfection", "definition_version": "99e1195c7d6f", "definition_digest": null, "required_operations": [], "support_state": "partial", "source_hashes": {"assay_lexicon": "99e1195c7d6f"}, "confidence": 0.99, "evidence": ["es was confirmed in SCLC clinical specimens. Knockdown assays using siRNAs targeting each of these", "cell proliferation. Moreover, siRNA-mediated knockdown of each MCM gene enhanced the cisplatin sens", "tion of cancer cell proliferation. Moreover, siRNA-mediated knockdown of each MCM gene enhanced", "ownregulation of MCM family members by siRNA transfection in SCLC cells, Figure S6: Apoptosis data obt"], "order_basis": "paper_text_order:1053", "id": "assay:1"}, {"role": "data_generation", "definition_id": "ihc", "definition_version": "99e1195c7d6f", "definition_digest": null, "required_operations": [], "support_state": "partial", "source_hashes": {"assay_lexicon": "99e1195c7d6f"}, "confidence": 0.99, "evidence": ["s, Figure S2: Histopathological findings and immunohistochemical analyses of MCM2, MCM4, MCM6, and MCM7 in ca", "2, Figure S3: Histopathological findings and immunohistochemical analyses of MCM2, MCM4, MCM6, and MCM7 in ca", "3, Figure S4: Histopathological findings and immunohistochemical analyses of MCM2, MCM4, MCM6, and MCM7 in no", "ds 3.1. Clinical Course of SCLC Patients and Immunostaining of Autopsy Tissues In this study, we obtaine"], "order_basis": "paper_text_order:1524", "id": "assay:2"}, {"role": "data_generation", "definition_id": "microarray", "definition_version": "99e1195c7d6f", "definition_digest": null, "required_operations": [], "support_state": "partial", "source_hashes": {"assay_lexicon": "99e1195c7d6f"}, "confidence": 0.93, "evidence": ["SCLC patients. Site of sample collection for microarray expression analysis. Clinical courses of the"], "order_basis": "paper_text_order:1903", "id": "assay:3"}, {"role": "data_generation", "definition_id": "apoptosis_assay", "definition_version": "99e1195c7d6f", "definition_digest": null, "required_operations": [], "support_state": "partial", "source_hashes": {"assay_lexicon": "99e1195c7d6f"}, "confidence": 0.69, "evidence": ["siRNA transfection in SCLC cells, Figure S6: Apoptosis data obtained by flow cytometry from H82 and"], "order_basis": "paper_text_order:5703", "id": "assay:4"}, {"role": "data_generation", "definition_id": "flow_cytometry", "definition_version": "99e1195c7d6f", "definition_digest": null, "required_operations": [], "support_state": "partial", "source_hashes": {"assay_lexicon": "99e1195c7d6f"}, "confidence": 0.93, "evidence": ["cells, Figure S6: Apoptosis data obtained by flow cytometry from H82 and SBC-3 cells transfected with si"], "order_basis": "paper_text_order:5730", "id": "assay:5"}, {"role": "analysis", "definition_id": "group_comparison", "definition_version": "f2132e96ae6c7a4e", "definition_digest": null, "required_operations": ["group_summary", "welch_t", "bootstrap_mean_difference", "group_comparison_anova"], "support_state": "supported", "source_hashes": {"dsl_catalogue": "f2132e96ae6c7a4e"}, "confidence": 1.0, "evidence": ["One-way analysis of variance (ANOVA) and Tukey’s post-hoc test were used for multiple group comparisons."], "order_basis": "consumes_earlier_output", "id": "assay:6"}]},"meta":{"api_version":"v1","automation_ladder_snapshot":"ba34b49490d9bfaf","automation_ladder_caveats":["Method extraction is rule-based and has no hand-judged accuracy sample. Evidence bands order textual support; method agreement intervals are null (n=0), never probabilities. Work-type validation does not validate methods.","Operation coverage describes only explicitly named methods. It does not prove a complete protocol, compatible parameters, successful compilation or re-execution. Unrecognised or ambiguous methods require review.","Data reachability is a textual accession or public-data statement. No dataset was downloaded or checked for access, completeness or licence.","Capabilities are planning states seeded from the dated equipment register. No bench ownership, completed quote or partner booking is inferred. Procurement counts are dependencies, not guaranteed replications or financial returns.","Tier and blocker counts are deterministic assessments of this corpus, not measured agreement. R3 is reserved for procurement; unresolved methods and data require human work (R4). The most restrictive axis wins, with capability, method, data as tie-breaks. Resolving one blocker can leave another at the same tier."],"engine":"corpus_engine","engine_provider":"rule_based_v1+lex99e1195c7d6f","run_id":"run-20261023T122449232913","source":"esearch","source_detail":"PubMed mirror biomed_pubmed (read-only)","run_status":"complete","imported_at":"2026-11-03T20:16:52+00:00","generated_at":"2026-11-04T03:34:17+00:00","total_papers":5529,"total_assays_tracked":29,"automatable_assay_families":6,"validated":true,"caveat_count":9,"blocking_caveats":5,"caveats":[{"code":"low_evidence_dominates","basis":["4,152 of 5,529 classifications (75.1%) matched no cue evidence and sit at the 0.05 floor.","34 of 230 data_only calls (14.8%) are in that group."],"claim":"Work type and confidence bands","gloss":"Most records were classified from their title and framing alone, with assay-cue coverage at zero.","detail":"Most classifications in this run rest on no matched evidence at all. At the evidence floor the work type comes from title framing and a fixed prior, not from anything in the paper, so the published work-type split should be read as a rough triage signal rather than a measured distribution. The impact is bounded but not removed: since 2026-10-23 the engine excludes floor-confidence records from the shortlist entirely and publishes them separately as held out, so the recommendation is unaffected even though the census is.","status":"unverified","severity":"high"},{"code":"runtime_is_modelled","basis":["Runtime is summed from published per-assay hour figures. Timing awaits the first executed replication.","4,407 of 5,529 records (79.7%) model to 0.00 hours because no assay was matched, which the ranking then reads as \"cheapest\".","0 of 10 shortlisted records carry a 0.00-hour estimate."],"claim":"Estimated replication runtime","gloss":"The hour figures are estimates built from assay mentions; timing awaits the first executed replication.","detail":"The hour figures are a cost model derived from the bench steps implied by each matched assay family. The first executed replication will supply measured timing. Records without an assay match currently receive a zero-hour model value.","status":"unverified","severity":"high"},{"code":"signal_score_without_citations","basis":["5,529 of 5,529 records (100.0%) have no citation count from the source metadata."],"claim":"Signal score","gloss":"The signal score uses publication-type weight because the mirror supplied zero citation counts.","detail":"The source supplied no citation counts for any record in this run, so the signal score is publication-type weight only. The citation term of the ranking is inert here, and the shortlist is ordered by publication type alone.","status":"unverified","severity":"high"},{"code":"abstract_absent","basis":["1,667 of 5,529 records (30.2%) carry no abstract at all."],"claim":"Evidence base for classification","gloss":"Some records contain a title and publication type only, defining the available classification evidence.","detail":"Where the mirror contains a title and publication types only, those fields define the classifier evidence. A methods section is required for fuller automated and human review.","status":"unverified","severity":"medium"},{"code":"classifier_agreement_measured","basis":["Published two-way decision agreement 77.7% (310 of 399 decidable records) from a stratified hand-check of 438 real records.","Three-way diagnostic agreement 73.9% (288 of 390 decidable records).","data_only agreement 75.2% (100 of 133 decidable).","48 record(s) could not be decided from title and abstract and were excluded from the denominator.","56 analysis-only records were published under another work type, so the data_only share is not an upper bound."],"claim":"Published automatable decision","gloss":"This figure has been checked against a human reading the same papers, so we know how often it is right.","detail":"The published automatable / not-automatable distribution comes from a rule-based classifier that was hand-checked against a fixed ground-truth definition. The agreement rates below are measured, not estimated. The three-way work type remains a diagnostic and is reported separately.","status":"measured","severity":"high"},{"code":"llm_comparison_not_measured","basis":["rule_based_v1+lex99e1195c7d6f produced 5,529 of 5,529 classifications.","Measured on 438 labelled records; these are RULE-BASED figures, not model results."],"claim":"Rule-based versus LLM agreement","gloss":"Every number here is the rule engine’s own. Model comparison begins when a working API credential is connected and measured.","detail":"The published two-way decision agreed with a human reading on 310 of 399 decidable records (77.7%). The diagnostic three-way label agreed on 288 of 390 decidable records (73.9%). Every percentage in this run belongs to the rule engine. Model comparison begins when a working API credential is connected and measured.","status":"not_measured","severity":"high"},{"code":"confidence_is_a_band","basis":["low band: 135 of 210 hand-judged records were correct, 64.3% [57.6, 70.5] (95% CI).","medium band: 80 of 104 hand-judged records were correct, 76.9% [68.0, 84.0] (95% CI).","high band: 73 of 76 hand-judged records were correct, 96.0% [89.0, 98.7] (95% CI).","A fitted calibrated probability was built, measured and withdrawn: it overstated held-out accuracy and reorders nothing."],"claim":"Confidence band and evidence score","gloss":"The confidence band carries a measured accuracy interval; 0.85 represents relative rank strength.","detail":"Confidence on this run is a BAND plus its measured accuracy interval. The number stored alongside each record is a monotone evidence score that orders records; 0.85 represents relative rank strength. A fitted probability was withdrawn after it overstated held-out accuracy. Threshold on the band.","status":"measured","severity":"medium"},{"code":"three_way_split_is_diagnostic","basis":["The corpus is published at the two-way decision: automatable or not-automatable. The three-way split (data_only / physical / mixed) is published as a diagnostic with its measured reliability attached, not as a claim, because the rule engine's `mixed` call cannot be defended.","The engine called 22 record(s) mixed; 10 matched the human judgement (45.5%, 95% CI 26.9-65.3).","The engine's `mixed` call is right on 10/22 hand-judged records (45.5%, 95% CI 26.9%-65.3%); a constant `physical` guess scores 36.4%.","The engine's `mixed` call does not reliably beat a constant `physical` guess on the hand-judged records it labels mixed.","The sign of that difference flips between two independent samples, so the three-way refinement is not demonstrably informative.","The mixed stratum contributes a disproportionate share of errors relative to its size.","At title-only depth the physical/mixed split collapses: a title says that work was done, not whether it was also analysed."],"claim":"The published decision is two-way","gloss":"The three-way split is shown for diagnosis only. The published split is two ways.","detail":"Count and filter the corpus on automatable versus not-automatable. The data_only / physical / mixed split remains an internal engine diagnostic because the mixed call has lower measured reliability.","status":"measured","severity":"medium"},{"code":"automatable_flag_unproven","basis":["6 of 29 assay families are marked automatable now: meta_analysis, machine_learning, survival_analysis, pca, molecular_docking, differential_expression.","The flag is a rule over assay family and work type; validation begins with the first executed replication.","It inherits the 75.2% data_only agreement rate, because the flag requires the record to be analysis-only."],"claim":"Automatable now","gloss":"This flag marks assay families the rules classify as data-only. The first executed replication will validate it.","detail":"This flag marks families the rules consider replicable from data alone. Its validity depends on the analysis-only classification and will be measured through an executed replication.","status":"unverified","severity":"medium"}],"confidence_policy":"band_with_measured_interval","confidence_contract":{"policy":"band_with_measured_interval","summary":"Confidence is reported as a BAND with a measured accuracy interval. The raw evidence score supplies monotone ordering. A fitted point estimate was withdrawn after it overstated held-out accuracy.","evidence_score":"A monotone evidence score in [0,1] built from cue mass, axis separation and text coverage. Use it to order records. Interpret 0.85 as relative rank strength.","confidence_band":"low | medium | high. Consumers threshold on this value.","band_accuracy":"Wilson 95% interval on the measured agreement of the hand-judged records in this band.","calibrated_confidence":"WITHDRAWN. Reintroduction requires held-out evidence demonstrating reliable estimates across every bin."},"band_accuracy":{"low":{"n":210,"low":0.576,"band":"low","high":0.7046,"agree":135,"accuracy":0.6429},"high":{"n":76,"low":0.8903,"band":"high","high":0.9865,"agree":73,"accuracy":0.9605},"medium":{"n":104,"low":0.6795,"band":"medium","high":0.8397,"agree":80,"accuracy":0.7692}},"provider":"rule_based_v1+lex99e1195c7d6f","lexicon_id":"99e1195c7d6f","contract_published_at":"2026-10-23T12:25:29.022232+00:00","confidence_is_band":true,"confidence_is_probability":false,"decision_taxonomy":"two_way","decidable_fraction_two_way":0.8854,"decidable_fraction_two_way_low":0.8565,"decidable_fraction_two_way_high":0.9143,"decidable_fraction_three_way":0.8586,"decidable_fraction_three_way_low":0.8287,"decidable_fraction_three_way_high":0.8884,"decidable_population":5529,"validation_sample_size":438,"three_way_cost_fraction":0.0268,"three_way_cost_records":148,"decision_counts":{"automatable":230,"not_automatable":5299},"decision_split":{"automatable":{"count":230,"share":0.04159884246699222},"not_automatable":{"count":5299,"share":0.9584011575330078}},"diagnostic_work_type_counts":{"mixed":24,"physical":5275,"data_only":230}}}